Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Synaptonemal complex central element protein 3 (SYCE3) is a meiosis-specific structural protein required for the assembly of the central element of the synaptonemal complex, a supramolecular protein structure that forms between homologous chromosomes during meiosis to facilitate their proper recombination and segregation[1][2][4][6]. SYCE3 acts as a molecular adapter during synapsis, directly binding the SYCP1 lattice and actively remodeling its structure to promote the maturation of the synaptonemal complex. It forms dimers and higher-order oligomers, physically recruits other central element proteins such as SYCE1 and SYCE2-TEX12, and is essential for functional chromosome synapsis and fertility[1][2][3][4][6]. Mutations or absence of SYCE3 disrupt the assembly of the central element of the synaptonemal complex, leading to aberrant meiosis and infertility but not directly to classical human disease syndromes[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Synaptonemal complex central element protein 3 (SYCE3).